市场调查报告书
商品编码
1218793
全球耳鼻喉激光设备市场:到 2028 年的预测——按类型、便携性、应用、最终用户和地区分析ENT Laser Devices Market Forecasts to 2028 - Global Analysis By Type, By Portability, By Application, By End Users and Geography |
根据Stratistics MRC,2022年全球耳鼻喉激光设备市场规模将达到1.2775亿美元,2028年将达到2.1109亿美元,预测期内占比8.73%,预计增长速度为的复合年增长率
术语“耳鼻喉科激光”也常用于指代 CO2 激光。 在耳鼻喉科,CO2 激光手术常用于治疗耳鼻喉疾病。 该手术是一种微创手术 (MIS),时间短,副作用少,并且绝对精确地完成。 通过在心臟中植入心臟起搏器,即使是老年人也能证明其效果。 特别是在医疗保健行业,激光技术正在全球范围内取得进展。 激光手术有很多优点,其中一些优点是微创、最小出血和无痛体验。 这些设备还具有减少手术所需时间的重要优势。 耳鼻喉科手术的技术发展导致耳鼻喉科激光仪器的使用增加。 不再需要输血,因为新型激光设备减少了出血量。 这些关键因素导致耳鼻喉科手术中激光设备的使用增加,最终将推动市场扩张。
根据 QualSight 发布的估计,到 2019 年美国将有 2300 万例 LASIK 视力矫正手术,近视手术占总数的大部分。
市场动态
驱动程序
耳鼻喉科疾病患病率增加
在受耳鼻喉科疾病影响的其他重要身体部位中,耳朵、鼻子和喉咙除了作为感觉器官外,对于维持身体的平衡感也至关重要。 由于新手术技术的发展,鼻窦炎、扁桃体炎、睡眠呼吸暂停和咽/口腔癌等耳鼻喉科疾病的住院人数正在增加。 此外,耳鼻咽喉科领域炎症性疾病的发生频率正在增加,需要最先进的治疗方法和治疗设备。 在此背景下,越来越多的供应商专注于扩大其耳鼻喉激光设备阵容,这可能会刺激市场扩张。
抑製剂
耳鼻喉科手术费用高
耳鼻喉手术的高成本是市场扩张的主要障碍。 耳鼻喉手术的总费用可能高达 10,000 美元。 发展中国家的人们可能负担不起如此昂贵的相关服务。 这些因素可能会阻碍 ENT 激光设备的普及,从而限制预测期内的增长。
机会
快速的技术改进
随着耳鼻喉科手术技术的发展,耳鼻喉科激光设备的使用越来越频繁。 一种新型激光设备减少了出血量,因此不再需要输血。 整容耳鼻喉手术现在在世界各地频繁进行,预计会显着增长。 这些关键因素将增加激光仪器在耳鼻喉科手术中的使用,并最终推动市场扩张。
威胁
严格的规定
由于遵守与激光产品安全相关的若干规则和指南非常重要,因此不同地区有不同的规定。 此外,耳鼻喉科手术的高成本、产品召回以及管理激光设备生产和使用的严格法律法规可能会在预测期内限制市场扩张。
COVID-19 的影响
意想不到的 COVID-19 大流行对市场造成了严重破坏,并导致了广泛的疾病和死亡。 此外,由于大流行,许多耳鼻喉科诊所关闭,择期手术(ESP)被取消,这对耳鼻喉科医疗器械的销售造成了影响。 此外,来自中国等其他国家的原材料和製成品的进出口也受到限制。 这些限制在 2020 年初造成供需失衡,导致耳鼻喉激光设备区域市场低迷。 然而,随着 COVID-19 病例数量的下降,封锁已经解除,原材料的进出口已经恢復。
预计在预测期内咽和颚癌将成为最大的细分市场
在预测期内,喉癌和唇癌部分预计将占据最大份额。 随着咽癌和口腔癌在世界上变得越来越普遍,它们在市场上占据主导地位。 今年美国约有 54,010 名成年患者(38,800 名男性和 15,210 名女性)被证实患有口腔和口咽癌。 癌症患者的增加是市场扩张的推动力。
预计在预测期内门诊手术中心部分的复合年增长率最高
由于耳鼻喉科手术的需求,门诊手术中心越来越受欢迎,预计门诊手术中心部分在预测期内的复合年增长率最高。 需求是由医疗保健基础设施的可及性、耳鼻喉手术的可负担性以及公众对手术成功或失败的意识不断增强所驱动的。 ASC 努力为患者提供最好的手术体验,同时向政府、其他利益相关者和患者收取尽可能低的费用。
市场份额最高的地区
由于每年耳鼻喉癌患者的数量不断增加,预计北美地区在预测期内将占最大份额。 北美地区约占整体市场增长的 43%。 此外,根据美国癌症协会的数据,到 2021 年,该国将新增约 12,960 例喉癌病例,导致约 3,770 人死亡。 此类事件将促进该地区的市场扩张。
复合年增长率最高的地区
在预测期内,预计亚太市场的复合年增长率最高。 亚洲耳鼻喉设备市场受到越来越多的微创耳鼻喉手术偏好、新兴国家可支配收入增加、人口迅速老龄化、市场参与者越来越关注印度以及监管标准的推动。由于诸如以下因素,预计该市场将增长的鬆动
主要发展
2021 年 9 月,波士顿科学完成了对 Lumenis LTD 的收购。 从 Baring Private Equity Asia 收购手术业务。 Lumenis Surgical 业务包括用于耳鼻喉科和泌尿外科手术的实施光纤和配件以及一流的激光系统,预计到 2021 年将产生约 2 亿美元的总收入。
2020 年 7 月,奥林巴斯公司推出了 SOLTIVE 超脉衝激光系统,该系统以紧凑的多功能封装提供卓越的性能。 其 150u 光纤的总输出功率是竞争对手较小光纤的 3 倍4。
本报告的内容
免费定制服务
订阅此报告的客户将免费获得以下自定义选项之一。
According to Stratistics MRC, the Global ENT Laser Devices Market is accounted for $127.75 million in 2022 and is expected to reach $211.09 million by 2028 growing at a CAGR of 8.73% during the forecast period. The term "ENT lasers" is also frequently used to refer to CO2 lasers. In Otolaryngology, CO2 laser surgery is frequently used to treat conditions of the ear, nose, and throat. It is a minimally invasive surgery (MIS) that is completed quickly, with few side effects, and with absolute precision. By having pacemakers in their hearts, the elderly can put it into action. Particularly in the healthcare industry, laser technology has become increasingly popular on a global scale. Laser surgery has many benefits, some of which are minimal invasion, minimal bleeding, and atraumatic experience. These devices also have the important advantage of reducing the amount of time needed for surgery. The use of ENT laser equipment has increased as a result of technological developments in ENT surgery. Blood transfusions are no longer necessary because new laser device types have reduced blood loss. These important factors have led to a rise in the use of laser equipment during ENT procedures, which will ultimately fuel market expansion.
According to estimates published by QualSight, the number of LASIK vision correction procedures in the US through 2019 reached 23 million, with myopia surgeries comprising the bulk of all surgeries.
Market Dynamics:
Driver:
The increasing prevalence of ENT disorders
The ear, nose, and throat, among other important body parts affected by ENT disorders, are crucial for maintaining the body's sense of balance in addition to serving as sensory organs. Hospitalizations for ENT conditions like sinusitis, tonsillitis, sleep apnea, and throat and mouth cancer have increased as a result of the development of new surgical techniques. In addition, the increasing frequency of inflammatory disorders of the ear, nose, and throat shows the need for cutting-edge treatment methods and devices. Due to this demand, a growing number of vendors are concentrating on extending their selection of ENT laser devices, which can spur market expansion.
Restraint:
High cost for ENT surgeries
The primary factor severely impeding the expansion of this market is the higher cost of ENT procedures. An ENT procedure can cost up to USD 10,000 in total. People in developing nations might not be able to afford such expensive related services. These factors may limit the growth during the forecast period by impeding the widespread adoption of ENT laser devices.
Opportunity:
Rapid technological improvements
ENT laser devices are now being used more frequently as a result of technological developments in ENT surgery. Blood transfusions are no longer necessary because new laser device types have reduced blood loss. Cosmetic ENT surgeries are now performed frequently all over the world and are predicted to grow significantly. These important factors have led to a rise in the use of laser equipment during ENT procedures, which will ultimately fuel market expansion.
Threat:
Stringent regulations
Regulations differ from region to region because it's crucial to follow several rules and guidelines related to the security of laser products. Furthermore, the high cost of ENT procedures, product recalls, and strict laws and regulations governing the production and use of laser devices could restrain market expansion during the forecast period.
COVID-19 Impact
A unforeseen COVID-19 outbreak that resulted in significant market damage and widespread illness and death. Additionally, due to the pandemic, many ENT clinics have closed and elective surgical procedures (ESPs) have been discontinued, which has hurt the sale of ENT medical devices. Additionally, there were restrictions on the import and export of raw materials and other finished goods from other nations, such as China. These restrictions led to a supply-demand imbalance in early 2020, which is what caused the regional market for ENT laser devices to slow down. However, lockdowns have been lifted and raw material import and export have resumed as a result of the declining number of COVID-19 cases.
The Throat and Mouth Cancer segment is expected to be the largest during the forecast period
The Throat and Mouth Cancer segment is anticipated to witness largest share during the projection period. Throat and mouth cancer dominated the market because it is becoming more and more common in the world. About 54,010 adult patients (38,800 men and 15,210 women) were found to have oral and oropharyngeal cancer in the United States this year. This increase in cancer cases fuels market expansion.
The Ambulatory Surgical Centers segment is expected to have the highest CAGR during the forecast period
The market's popularity of ambulatory surgical centres has grown due to the demand for ENT procedures therefore Ambulatory Surgical Centers segment is anticipated to register highest CAGR over the forecast period. Demand is being driven by the accessibility of health infrastructure, the affordability of ENT procedures, and growing public awareness of the success or failure of procedures. ASCs strive to give patients the best surgical experience while charging the government, other parties, and patients the least amount of money.
Region with largest share:
Due to the rising number of ear, nose, and throat cancer cases each year, North America region is expected to hold largest share during the forecast period. The North America region accounts for nearly 43% of the market's overall growth. Additionally, according to the American Cancer Society, there will be nearly 12,960 new cases of laryngeal cancer in the country in 2021, contributing to about 3770 fatalities. Such occurrences fuel market expansion in the region.
Region with highest CAGR:
During the forecast period, the market in Asia Pacific is anticipated to have the highest CAGR. The Asian ENT devices market is anticipated to grow as a result of factors including a rising preference for minimally invasive ENT procedures, rising disposable income in developing nations, a rapidly increasing elderly population, increased focus on India by market players, and laxer regulatory standards.
Key players in the market
Some of the key players profiled in the ENT Laser Devices Market include IRIDEX Corp., Shanghai Fosun Pharmaceutical (Group) Co. Ltd., Smith and Nephew plc, Sunny Optoelectronic Technology Co. Ltd, Limmer Laser GmbH, Lumenis Ltd., Olympus Corp., XIO Group, ARC Laser GmbH., Boston Scientific Corp. and El.En. S.p.a.
Key Developments:
In September 2021, Boston Scientific Corp, Closes the Acquisition of Lumenis LTD. Surgical Business from Baring Private Equity Asia. The Lumenis surgical business inculcates fibres and accessories and premier laser systems implemented for otolaryngology, and urology procedures, with total revenue expected to be around $200 million for 2021.
In July 2020, Olympus Corp launched SOLTIVE Super Pulsed Laser systems to deliver exceptional performance in a small and versatile package. Its 150u fibre can provide approximately three times the total power of competitor's small fibers4.
Types Covered:
Portability Covered:
Applications Covered:
End Users Covered:
Regions Covered:
What our report offers:
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options: